Exelon (NASDAQ:EXC) Stock Acquired Rep. Marjorie Taylor Greene

Representative Marjorie Taylor Greene (R-Georgia) recently bought shares of Exelon Corporation (NASDAQ:EXC). In a filing disclosed on August 29th, the Representative disclosed that they had bought between $15,001 and $50,000 in Exelon stock on August 28th.

Representative Marjorie Taylor Greene also recently made the following trade(s):

  • Purchased $1,001 – $15,000 in shares of UnitedHealth Group (NYSE:UNH) on 8/28/2025.
  • Purchased $1,001 – $15,000 in shares of Southern (NYSE:SO) on 8/28/2025.
  • Purchased $1,001 – $15,000 in shares of Merck & Co., Inc. (NYSE:MRK) on 8/28/2025.
  • Purchased $1,001 – $15,000 in shares of PepsiCo (NASDAQ:PEP) on 8/28/2025.
  • Purchased $1,001 – $15,000 in shares of Morgan Stanley (NYSE:MS) on 8/28/2025.
  • Purchased $1,001 – $15,000 in shares of Novo Nordisk A/S (NYSE:NVO) on 8/28/2025.
  • Purchased $15,001 – $50,000 in shares of Ryman Hospitality Properties (NYSE:RHP) on 8/28/2025.
  • Purchased $1,001 – $15,000 in shares of Alphabet (NASDAQ:GOOG) on 8/28/2025.
  • Purchased $1,001 – $15,000 in shares of MercadoLibre (NASDAQ:MELI) on 8/28/2025.
  • Purchased $1,001 – $15,000 in shares of United Parcel Service (NYSE:UPS) on 8/28/2025.

Exelon Stock Performance

Exelon stock opened at $43.68 on Tuesday. The company has a current ratio of 0.95, a quick ratio of 0.85 and a debt-to-equity ratio of 1.66. The firm has a 50-day moving average of $43.95 and a 200-day moving average of $44.21. The firm has a market cap of $44.12 billion, a P/E ratio of 16.61, a P/E/G ratio of 2.56 and a beta of 0.41. Exelon Corporation has a 1-year low of $35.94 and a 1-year high of $48.11.

Exelon (NASDAQ:EXCGet Free Report) last posted its earnings results on Thursday, July 31st. The company reported $0.39 earnings per share for the quarter, topping analysts’ consensus estimates of $0.37 by $0.02. The company had revenue of $5.43 billion during the quarter, compared to analyst estimates of $5.47 billion. Exelon had a net margin of 11.16% and a return on equity of 9.85%. Exelon’s revenue for the quarter was up 1.2% on a year-over-year basis. During the same period in the prior year, the business posted $0.47 earnings per share. Exelon has set its FY 2025 guidance at 2.640-2.740 EPS. Sell-side analysts expect that Exelon Corporation will post 2.64 EPS for the current year.

Exelon Announces Dividend

The company also recently announced a quarterly dividend, which will be paid on Monday, September 15th. Stockholders of record on Monday, August 11th will be issued a dividend of $0.40 per share. This represents a $1.60 dividend on an annualized basis and a dividend yield of 3.7%. The ex-dividend date is Monday, August 11th. Exelon’s dividend payout ratio is currently 60.84%.

Hedge Funds Weigh In On Exelon

Institutional investors and hedge funds have recently made changes to their positions in the business. Centaurus Financial Inc. bought a new stake in shares of Exelon during the second quarter valued at approximately $201,000. Orion Porfolio Solutions LLC boosted its holdings in Exelon by 37.8% in the second quarter. Orion Porfolio Solutions LLC now owns 25,952 shares of the company’s stock worth $1,127,000 after purchasing an additional 7,119 shares during the last quarter. Thrivent Financial for Lutherans boosted its holdings in Exelon by 61.7% in the second quarter. Thrivent Financial for Lutherans now owns 66,707 shares of the company’s stock worth $2,894,000 after purchasing an additional 25,458 shares during the last quarter. MASTERINVEST Kapitalanlage GmbH purchased a new stake in Exelon in the second quarter worth approximately $825,000. Finally, Stance Capital LLC purchased a new stake in Exelon in the second quarter worth approximately $1,843,000. Institutional investors own 80.92% of the company’s stock.

Analysts Set New Price Targets

A number of analysts have recently weighed in on the stock. UBS Group reiterated a “neutral” rating and set a $48.00 target price (up from $47.00) on shares of Exelon in a report on Friday, July 11th. KeyCorp decreased their price target on shares of Exelon from $39.00 to $37.00 and set an “underweight” rating for the company in a research note on Wednesday, July 16th. Finally, Morgan Stanley reissued an “outperform” rating on shares of Exelon in a research note on Thursday, August 21st. Five equities research analysts have rated the stock with a Buy rating, four have issued a Hold rating and one has issued a Sell rating to the stock. According to MarketBeat, the stock has a consensus rating of “Hold” and a consensus price target of $47.20.

Check Out Our Latest Report on EXC

About Representative Greene

Marjorie Taylor Greene (Republican Party) is a member of the U.S. House, representing Georgia’s 14th Congressional District. She assumed office on January 3, 2021. Her current term ends on January 3, 2027.

Greene (Republican Party) is running for re-election to the U.S. House to represent Georgia’s 14th Congressional District. She declared candidacy for the 2026 election.

About Exelon

(Get Free Report)

Exelon Corporation, a utility services holding company, engages in the energy distribution and transmission businesses in the United States and Canada. The company is involved in the purchase and regulated retail sale of electricity and natural gas, transmission and distribution of electricity, and distribution of natural gas to retail customers.

Featured Articles

Receive News & Ratings for Exelon Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Exelon and related companies with MarketBeat.com's FREE daily email newsletter.